Matches in Nanopublications for { ?s ?p "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP390368.RA-mGV1B91EN2rlhdoKRlW57fl4hEF7mKQ7cyxyE3TygA130_assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390368.RA-mGV1B91EN2rlhdoKRlW57fl4hEF7mKQ7cyxyE3TygA130_provenance.
- NP717825.RACoV2hcEzxREmwyWfMyJASd6QBRHymGSDzZV0DjMt2dg130_assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717825.RACoV2hcEzxREmwyWfMyJASd6QBRHymGSDzZV0DjMt2dg130_provenance.
- assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP916222.RAVAORKHXLTv6VaFeTGvlbbBDJnVPqBKFwbLihfSgbiyo130_assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916222.RAVAORKHXLTv6VaFeTGvlbbBDJnVPqBKFwbLihfSgbiyo130_provenance.
- NP717822.RA5XacVBzBVrhNn0IQMkSXx6-53C0UI7GxU54zrw-YcO4130_assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717822.RA5XacVBzBVrhNn0IQMkSXx6-53C0UI7GxU54zrw-YcO4130_provenance.
- NP717824.RAR2k4rm2jcfuJJEp7FR_Qjhi2l74Gm0NQfpcPUNULPIU130_assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717824.RAR2k4rm2jcfuJJEp7FR_Qjhi2l74Gm0NQfpcPUNULPIU130_provenance.
- assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP808766.RAMQ8c8zxYrOCNhMwHV1HUwHsqSm7Q9qW9RHU4QFPmexg130_assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808766.RAMQ8c8zxYrOCNhMwHV1HUwHsqSm7Q9qW9RHU4QFPmexg130_provenance.
- assertion description "[Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.